Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian F Gage

Showing results (121-130 of 139) with videos related to

Pageof 14
Sort By:
HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery|February 6, 2018
Postoperative Myocardial Injury and Inflammation Is Not Blunted by a Trial of Atorvastatin in Orthopedic Surgery PatientsAnne R Bass, Jackie D Szymonifka, Matthew T Rondina, et al.
Circulation|February 10, 2012
Admission international normalized ratio levels, early treatment strategies, and major bleeding risk among non-ST-segment-elevation myocardial infarction patients on home warfarin therapy: insights from the National Cardiovascular Data RegistrySumeet Subherwal, Eric D Peterson, Anita Y Chen, et al.
Blood|March 28, 2007
Genetic-based dosing in orthopedic patients beginning warfarin therapyEric A Millican, Petra A Lenzini, Paul E Milligan, et al.
European Heart Journal|October 23, 2014
Risk model for estimating the 1-year risk of deferred lesion intervention following deferred revascularization after fractional flow reserve assessmentJeremiah P Depta, Jayendrakumar S Patel, Eric Novak, et al.
Circulation|April 1, 2009
Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding ScoreSumeet Subherwal, Richard G Bach, Anita Y Chen, et al.
Pharmacogenomics|December 19, 2014
Genotype and risk of major bleeding during warfarin treatmentVivian K Kawai, Andrew Cunningham, Susan I Vear, et al.
Clinical Pharmacology and Therapeutics|February 2, 2022
Warfarin Dosing in Patients With CYP2C9*5 Variant AllelesKathryn J Lindley, Nita A Limdi, Larisa H Cavallari, et al.
Annals of Internal Medicine|June 30, 2025
Catheter and Surgical Ablation for Atrial Fibrillation : A Systematic Review and Meta-analysisBryce Montané, Shiyang Zhang, Jonathan D Wolfe, et al.
Heart (British Cardiac Society)|June 4, 2015
Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacementBrian R Lindman, Jared G Breyley, Joel D Schilling, et al.
HIV Clinical Trials|December 20, 2011
Pharmacogenomics of HIV therapy: summary of a workshop sponsored by the National Institute of Allergy and Infectious DiseasesDavid W Haas, Daniel R Kuritzkes, Marylyn D Ritchie, et al.
Pageof 14

Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery|February 6, 2018
Postoperative Myocardial Injury and Inflammation Is Not Blunted by a Trial of Atorvastatin in Orthopedic Surgery PatientsAnne R Bass, Jackie D Szymonifka, Matthew T Rondina, et al.
Circulation|February 10, 2012
Admission international normalized ratio levels, early treatment strategies, and major bleeding risk among non-ST-segment-elevation myocardial infarction patients on home warfarin therapy: insights from the National Cardiovascular Data RegistrySumeet Subherwal, Eric D Peterson, Anita Y Chen, et al.
Blood|March 28, 2007
Genetic-based dosing in orthopedic patients beginning warfarin therapyEric A Millican, Petra A Lenzini, Paul E Milligan, et al.
European Heart Journal|October 23, 2014
Risk model for estimating the 1-year risk of deferred lesion intervention following deferred revascularization after fractional flow reserve assessmentJeremiah P Depta, Jayendrakumar S Patel, Eric Novak, et al.
Circulation|April 1, 2009
Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding ScoreSumeet Subherwal, Richard G Bach, Anita Y Chen, et al.
Pharmacogenomics|December 19, 2014
Genotype and risk of major bleeding during warfarin treatmentVivian K Kawai, Andrew Cunningham, Susan I Vear, et al.
Clinical Pharmacology and Therapeutics|February 2, 2022
Warfarin Dosing in Patients With CYP2C9*5 Variant AllelesKathryn J Lindley, Nita A Limdi, Larisa H Cavallari, et al.
Annals of Internal Medicine|June 30, 2025
Catheter and Surgical Ablation for Atrial Fibrillation : A Systematic Review and Meta-analysisBryce Montané, Shiyang Zhang, Jonathan D Wolfe, et al.
Heart (British Cardiac Society)|June 4, 2015
Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacementBrian R Lindman, Jared G Breyley, Joel D Schilling, et al.
HIV Clinical Trials|December 20, 2011
Pharmacogenomics of HIV therapy: summary of a workshop sponsored by the National Institute of Allergy and Infectious DiseasesDavid W Haas, Daniel R Kuritzkes, Marylyn D Ritchie, et al.
Pageof 14